Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ZYNE

Zynerba

$18.20

-0.18 (-0.98%)

, GWPH

GW Pharmaceuticals

$94.99

0.85 (0.90%)

07:58
06/12/17
06/12
07:58
06/12/17
07:58
Recommendations
Zynerba, GW Pharmaceuticals analyst commentary at Maxim »

Zynerba an…

ZYNE

Zynerba

$18.20

-0.18 (-0.98%)

GWPH

GW Pharmaceuticals

$94.99

0.85 (0.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jun

GWPH

GW Pharmaceuticals

$94.14

-3.28 (-3.37%)

08:12
06/09/17
06/09
08:12
06/09/17
08:12
Recommendations
GW Pharmaceuticals analyst commentary at Maxim »

GW Pharmaceuticals orphan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GWPH

GW Pharmaceuticals

$94.14

-3.28 (-3.37%)

08:08
06/09/17
06/09
08:08
06/09/17
08:08
Hot Stocks
GW Pharmaceuticals treatment of Fragile X syndrome granted orphan status »

On June 6, GW…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GWPH

GW Pharmaceuticals

$106.31

-1.49 (-1.38%)

08:50
05/25/17
05/25
08:50
05/25/17
08:50
Recommendations
GW Pharmaceuticals analyst commentary at Leerink »

NEJM validation for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GWPH

GW Pharmaceuticals

$106.31

-1.49 (-1.38%)

17:05
05/24/17
05/24
17:05
05/24/17
17:05
Hot Stocks
GW Pharmaceuticals announces publication of groundbreaking study of Epidiolex »

GW Pharmaceuticals, along…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
GWPH

GW Pharmaceuticals

$104.11

0.38 (0.37%)

07:21
05/15/17
05/15
07:21
05/15/17
07:21
Hot Stocks
GW Pharmaceuticals appoints Volker Knappertz, M.D. as Chief Medical Officer »

GW Pharmaceuticals (GWPH)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    May

GWPH

GW Pharmaceuticals

$109.13

-0.53 (-0.48%)

11:09
05/10/17
05/10
11:09
05/10/17
11:09
Earnings
GW Pharmaceuticals reported last night Q2 revenue $2.04M, consensus $2.55M »

The company reported Q2…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    May

GWPH

GW Pharmaceuticals

$115.82

-0.37 (-0.32%)

08:02
04/21/17
04/21
08:02
04/21/17
08:02
Initiation
GW Pharmaceuticals initiated at Maxim »

GW Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GWPH

GW Pharmaceuticals

$113.94

-2.31 (-1.99%)

16:31
04/18/17
04/18
16:31
04/18/17
16:31
Hot Stocks
GW Pharmaceuticals higlight new Epidiolex data released by AAN »

GW Pharmaceuticals noted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GWPH

GW Pharmaceuticals

$120.13

-1.28 (-1.05%)

07:40
03/29/17
03/29
07:40
03/29/17
07:40
Hot Stocks
GW Pharmaceuticals drug Epidiolex receives Orphan Drug Designation from EMA »

GW Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.